← FDA Drug Approvals (Drugs@FDA)
NALBUPHINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2019-02-06
Drug application
- FDA Application #
ANDA206506- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NALBUPHINE HYDROCHLORIDE
- Generic name
- Nalbuphine Hydrochloride
- Active ingredients
- NALBUPHINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- RISING
- First approval
- 2019-02-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown